Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Colorado

422 recruiting clinical trials across 15 cities in Colorado (CO). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
422
Total Trials
422
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Colorado

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00231400

Pompe Disease Registry Protocol

The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's...

Sponsor: Genzyme, a Sanofi CompanyEnrolling: 200020 locations
Glycogen Storage Disease Type IIPompe Disease
RECRUITINGNCT00315380

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the...

Sponsor: University of PennsylvaniaEnrolling: 70013 locations
Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss Syndrome
RECRUITINGNCT01209000

Nephrotic Syndrome Study Network

Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting...

Sponsor: University of MichiganEnrolling: 120020 locations
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
RECRUITINGNCT01524276

Product Surveillance Registry

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is...

Sponsor: MedtronicEnrolling: 10000020 locations
Cardiac Rhythm DisordersUrological DisordersNeurological Disorders+13
RECRUITINGNCT01574053

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and...

Sponsor: CHDI Foundation, Inc.Enrolling: 3500020 locations
Huntington's Disease
RECRUITINGNCT01694940

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Sponsor: Columbia UniversityEnrolling: 100017 locations
Mitochondrial DisordersMitochondrial Genetic DisordersMitochondrial Diseases+2
RECRUITINGPhase 2NCT01773278

Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Patients with biochemically confirmed SLOS are being treated with cholesterol supplementation and antioxidant medication. They are carefully monitored with visits to clinic,...

Sponsor: University of Colorado, DenverEnrolling: 1001 location
Smith-Lemli-Opitz SyndromeCone-Rod DystrophyHearing Loss
RECRUITINGNCT01904851

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that...

Sponsor: Baylor Research InstituteEnrolling: 1400020 locations
Peripheral Arterial Disease
RECRUITINGNCT02012699

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal...

Sponsor: University of NebraskaEnrolling: 99999920 locations
Pancreatic CancerThyroid CancerLung Cancer+47
RECRUITINGNCT02135705

LOWER: Lomitapide Observational Worldwide Evaluation Registry

This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and...

Sponsor: Amryt PharmaEnrolling: 30020 locations
Homozygous Familial Hypercholesterolemia
RECRUITINGPhase 1 / Phase 2NCT02140255

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 112020 locations
HIV Infection
RECRUITINGPhase 1 / Phase 2NCT02332668

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma...

Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: *...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 37017 locations
MelanomaLymphomaSolid Tumor+2
RECRUITINGPhase 1 / Phase 2NCT02343042

Selinexor and Backbone Treatments of Multiple Myeloma Patients

This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of...

Sponsor: Karyopharm Therapeutics INCEnrolling: 30020 locations
Multiple Myeloma
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGNCT02455193

Neuronal Effects of Exercise in Schizophrenia

This study plans to learn more about how common drugs prescribed to individuals with schizophrenia contribute to weight gain, as well as how exercise and diet impact appetite and...

Sponsor: University of Colorado, DenverEnrolling: 1401 location
Schizophrenia
RECRUITINGNCT02815891

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across...

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice....

Sponsor: Target PharmaSolutions, INC.Enrolling: 1500020 locations
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
RECRUITINGNCT02855476

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for...

HDClarity will seek at least 2500 research participants at different stages of Huntington's disease (HD). The primary objective is to collect a high quality CSF sample for...

Sponsor: University College, LondonEnrolling: 250020 locations
Huntington's Disease
RECRUITINGPhase 4NCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood...

Sponsor: VA Office of Research and DevelopmentEnrolling: 741020 locations
Prediabetic StateAtherosclerosisMetformin
RECRUITINGPhase 2NCT02932150

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with...

Sponsor: Gilead SciencesEnrolling: 15020 locations
Chronic Hepatitis B
RECRUITINGNCT03003299

PARTNER 3 Trial - Aortic Valve-in-Valve

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic bioprosthetic valve.

Sponsor: Edwards LifesciencesEnrolling: 12520 locations
Aortic StenosisAortic Stenosis, Severe
RECRUITINGPhase 3NCT03016819

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma...

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study...

Sponsor: Advenchen Laboratories, LLCEnrolling: 32520 locations
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1
RECRUITINGNCT03142152

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

The objective of this prospective, randomized, blinded clinical trial is to assess the safety and efficacy of the Carillon Mitral Contour System in treating heart failure with...

Sponsor: Cardiac Dimensions, Inc.Enrolling: 30020 locations
Functional Mitral RegurgitationHeart FailureMitral Valve Insufficiency+3
RECRUITINGNCT03297775

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical...

Sponsor: University of Colorado, DenverEnrolling: 7501 location
Rheumatoid ArthritisInterstitial Lung Disease
RECRUITINGPhase 2NCT03375307

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other...

This phase II trial studies how well olaparib works in treating patients with bladder cancer and other genitourinary tumors with deoxyribonucleic acid (DNA)-repair defects that...

Sponsor: National Cancer Institute (NCI)Enrolling: 6017 locations
Advanced Bladder CarcinomaAdvanced Genitourinary System CarcinomaMetastatic Bladder Carcinoma+3
RECRUITINGNCT03428048

Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.

Information gathered from the patients via a disease specific questionnaire will be married to data from the National Cardiovascular Data Registry (NCDR®). Details will be...

Sponsor: Cardiovascular Innovation and Research InstituteEnrolling: 10001 location
Coronary Artery DiseaseAtrial Fibrillation (AF)
RECRUITINGNCT03452774

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool,...

Sponsor: Massive Bio, Inc.Enrolling: 5000020 locations
Cancer, MetastaticCancerCancer of Pancreas+40
RECRUITINGPhase 2 / Phase 3NCT03474029

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

This study is conducted to compare the safety and effectiveness of a novel short 6-week regimen of daily rifapentine (6wP, experimental arm) with a comparator arm of 12-16 weeks...

Sponsor: Centers for Disease Control and PreventionEnrolling: 340016 locations
Latent Tuberculosis
RECRUITINGNCT03478553

The Genetics of Pulmonary Fibrosis

This study seeks to screen first degree family members of people with Idiopathic Pulmonary Fibrosis (IPF) for the earliest signs of lung fibrosis.

Sponsor: University of Colorado, DenverEnrolling: 10001 location
Idiopathic Pulmonary Fibrosis (IPF)
RECRUITINGPhase 3NCT03683251

Extension Study for the Port Delivery System With Ranibizumab (Portal)

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular...

Sponsor: Hoffmann-La RocheEnrolling: 100020 locations
Neovascular Age-Related Macular Degeneration
RECRUITINGNCT03754114

Brain Oxygen Optimization in Severe TBI, Phase 3

BOOST3 is a randomized clinical trial to determine the comparative effectiveness of two strategies for monitoring and treating patients with traumatic brain injury (TBI) in the...

Sponsor: University of MichiganEnrolling: 109420 locations
Brain Injuries, Traumatic

Showing 30 of 422 trials in Colorado. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 422 clinical trials actively recruiting participants in Colorado. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Colorado include Cystic Fibrosis, Multiple Myeloma, Multiple Sclerosis, Breast Cancer, Melanoma. Each has multiple active trials across research centers in the state.

Major trial sites in Colorado include Aurora, Denver, Colorado Springs, Lakewood, Fort Collins. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.